Mediation by nitric oxide of neurogenic relaxation of the urinary bladder neck muscle in sheep. by Thornbury, Keith D. et al.
Journal of Physiology (1992), 451, pp. 133-144 133
With 5 figures
Printed in Great Britain
MEDIATION BY NITRIC OXIDE OF NEUROGENIC RELAXATION OF
THE URINARY BLADDER NECK MUSCLE IN SHEEP
BY K. D. THORNBURY, M. A. HOLLYWOOD AND N. G. McHALE
From the Department of Physiology, School of Biomedical Science, the Queen's
University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland
(Received 5 August 1991)
SUMMARY
1. Mechanical recordings were made in vitro from circularly oriented strips of the
bladder neck muscle of sheep. In the absence of drugs, electrical field stimulation at
frequencies of 0 2-1 Hz evoked clear-cut relaxations throughout 1 min stimulation
periods, while higher stimulus frequencies (2-8 Hz) evoked variable responses
consisting of relaxation, contraction or a mixture of both. All of the responses were
abolished by tetrodotoxin (10-6 M).
2. The contractions were reduced by guanethidine (10-6 M) and atropine (10-6 M),
so that in the presence of these drugs clear-cut relaxations were obtained at 0 2-8 Hz
stimulation, indicating that the relaxations were mediated by non-adrenergic, non-
cholinergic (NANC) nerves.
3. The NANC relaxations were blocked by L-NG nitro arginine methyl ester
(L-NAME), an inhibitor of nitric oxide synthesis. The antagonism by L-NAME was
reversed by L-arginine.
4. Another feature of the NANC relaxation was 'rebound contraction' which
occurred when the stimulus was switched off. The rebound contraction was also
blocked by L-NAME and restored by L-arginine.
5. The relaxations and rebound contractions were unaffected by either a,,?-
methylene ATP (10-5 M) or 2-methylthio ATP (10-5 m).
6. S-Nitroso-L-cysteine, a substance which spontaneously releases NO at physio-
logical pH, mimicked the relaxation and rebound contraction produced by nerve
stimulation.
7. It is concluded that nerve-evoked relaxation of the bladder neck is mediated by
NO, or a closely related substance such as S-nitroso-L-cysteine.
INTRODUCTION
There has been considerable debate as to how the internal smooth muscle sphincter
at the outlet of the urinary bladder opens during voiding. One proposal is that fibres
of the sphincter continue into the base of the ,etrusor muscle in such a way that
when the latter contracts it pulls the sphincter open (Denny-Brown & Robertson,
1933 a, b; Kuru, 1965). Other studies, however, have shown that the sphincter has an
inhibitory non-adrenergic, non-cholinergic (NANC) innervation which causes
relaxation both of the intrinsic tone inherent in this muscle, and of agonist-induced
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contractions (Andersson, Mattiasson & Sjogren, 1983; Klarskov, Gerstenberg,
Ramirez & Hald, 1983; Hills, Meldrum, Klarskov & Burnstock, 1984; Klarskov,
1987; Mattiasson, Andersson, Andersson, Larsson, Sjogren & Uvelius, 1990).
Although several putative neurotransmitters including vasoactive intestinal poly-
peptide (VIP), adenosine triphosphate (ATP), adenosine and 5-hydroxytryptamine
(5-HT) cause relaxation of the internal sphincter, antagonizing these substances has
no effect on the response to nerve stimulation (Hills et al. 1984; Klarskov, 1987).
Another potential neurotransmitter which has not previously been considered is
nitric oxide (NO). Some central and peripheral neurones contain an enzyme
apparently identical to endothelial NO-synthase (Bredt, Hwang & Snyder, 1990),
which forms NO from the terminal guanidino nitrogens of L-arginine (Palmer,
Ashton & Moncada, 1988). A number of recent studies have concluded that NO
mediates NANC inhibition in a variety of visceral organs including the anococcygeus
muscle (Gillespie, Xiarong & Martin, 1989; Gibson, Mirzazadeh, Hobbs & Moore,
1990) the gastrointestinal tract (Bult, Boeckxstaens, Pelckmans, Jordaens, Van
Maercke & Herman, 1990; Boeckxstaens, Pelckmans, Bult, De Man, Herman & Van
Maercke, 1991; Dalziel, Thornbury, Ward & Sanders, 1991; Desai, Sessa & Vane,
1991; Thornbury, Ward, Dalziel, Carl, Westfall & Sanders, 1991), and corpus
cavernosum muscle (Ignarro, Bush, Buga, Wood, Fukuto & Rajfer, 1990). Such
conclusions are supported by the following observations: (1) specific inhibitors of
NO-synthase block the effects of nerve stimulation; (2) L-arginine, the substrate for
NO-synthase, competitively reverses the effect of NO-synthase inhibition, but D-
arginine is without effect; (3) NO and NO-releasing compounds mimic the inhibitory
effects of nerve stimulation. The aim of the present study was to determine whether
NO mediates NANC relaxation of the internal smooth muscle sphincter at the
bladder neck.
METHODS
Urinary bladders of sheep of either sex were obtained from an abattoir approximately 15 min
after slaughter and transported to the laboratory for dissection in oxygenated Krebs solution.
Circularly oriented rings were cut from the region of the bladder just below the trigone and these
were opened and the mucosa removed by sharp dissection to give strips with approximate
dimensions of 10 mm x 4 mm x 4 mm. The strips were mounted in organ baths (volume 5 ml), with
initial tension adjusted to 6 mN, and perfused with Krebs solution of composition (mM): NaCl, 120;
NaHCO3, 25; KCl, 5 9; NaH2P04, 1-2; CaCl2, 2-5; MgCl2, 1C2; glucose, 11; gassed with 02 (95%)
and C02 (5%). Tension changes were measured with Statham UC3 and Dynamometer UF1
isometric transducers the outputs of which were written on Gould 2400S and Lectromed MC 216
chart recorders. Field stimulation was applied via platinum ring electrodes mounted at either end
of the tissue strip. Pulses of 0-3 ms duration were delivered in trains at constant frequencies of 0-2,
0 5, 1 2, 4 and 8 Hz from Grass S88 and SIt stimulators set at nominal output voltages of 50 V.
Stimulation periods always lasted 1 min and the recovery time between stimuli was at least 5 min.
In nerve stimulation experiments the preparations were perfused continuously with Krebs solution
and drugs were delivered in the perfusing solution. However, when testing the effect of S-nitroso-
L-cysteine a different approach was used since this compound has a half-life of less than 30 s (Myers,
Minor, Guerra, Bates & Harrison, 1990; Bates, Aldape & Baker, 1991). In these experiments the
tissue was mounted in 20 ml organ baths which were continuously bubbled with 02 (95%) and
C02 (5 %). These baths were also perfused, but when cumulative additions of S-nitroso-L-cysteine
were made the perfusion was switched off. The S-nitroso-L-cysteine was then washed out by
recommencing the perfusion.
S-Nitroso-L-cysteine was synthesized by reacting L-cysteine with sodium nitrite under acidic
conditions as described previously (Field, Dilts, Ravichandran, Lenhert & Carnahan, 1978;
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Kowaluk & Fung, 1990). Reactant solution contained in 1 N-HCI (5 ml), MeOH (5 ml), con-
centrated H2SO4 (0 5 ml), sodium nitrite (10 mM) and L-cysteine (5 mM). In control experiments,
dilutions of the reactant solution (containing all of the reactants except L-cysteine) equivalent to
S-nitroso-L-cysteine (10-5 M) had no effect on the preparation. Other drugs were used as follows:
tetrodotoxin (TTX; Sigma); guanethidine sulphate (Sigma); atropine sulphate (Sigma); L-N'-nitro
arginine methyl ester (L-NAME; Sigma); L-arginine (Sigma; D-arginine (Sigma); a,fi-methylene
adenosine triphosphate (a,,J-methylene ATP; Sigma); 2-methylthio adenosine triphosphate (2
methylthio ATP; Research Biochemicals Inc., USA), noradrenaline bitartrate (Sigma). All of these
were made up to their final concentration in the Krebs solution; all drugs present in each type of
experiment are stated in the figure legends. Summarized results are expressed throughout as mean
responses+ S.E.M, and statistical comparisons were made using ANOVA and Fischer's PLSD test,
taking the P < 0 05 level as significant.
RESULTS
Responses to electrical field stimulation
The effect of electrical field stimulation (0-2-8 Hz) was studied on an initial sample
of thirty-one bladder neck strips before addition of drugs. Clear-cut relaxations were
always apparent at the lower stimulus frequencies tested (0 2-1 Hz). At 0-2 Hz the
response consisted of individual relaxations coinciding with each stimulus pulse and
partially summated to give a tonic relaxation (Fig. 1, upper trace). At 0 5 and 1 Hz
summation was complete, giving tonic relaxations which reached their peak within
20 s. These were well maintained throughout the stimulus period and were followed
by a contraction which occurred after termination of the stimulus. This will
henceforth be referred to as the 'rebound contraction' (see below). The maximum
relaxation was obtained at 1 Hz and averaged 0-61 + 010 mN (n = 31). Relaxations
were also observed during stimulation at higher frequencies (2-8 Hz), although they
were partly or completely offset by contractions occurring during the stimulus
period. This contraction appeared either as a partial escape from the relaxation
during stimulation (e.g. response to 2 Hz, Fig. 1) or crossed the baseline to produce
an increase in tone above the resting level (e.g. response to 4 Hz, Fig. 1). The latter
contractions were reduced by a combination of guanethidine (10-6 M) and atropine
(106 M), so that the responses to the higher frequencies of stimulation also became
predominantly relaxant (e.g. Fig. 2). Relaxations, in contrast, were either unaffected
by guanethidine and atropine, or were further unmasked by these drugs, confirming
previous observations that they are NANC in character (Klarskov et al. 1983; Hills
et al. 1984; Klarskov, 1987). All of the responses to stimulation at frequencies of
0-2-8 Hz were completely abolished by TTX (10-6 M; n = 8), indicating that they
were neurally mediated (e.g. Fig. 1, lower trace).
Effect of L-NAME and L-arginine
In order to test whether products of the NO synthesis pathway mediate the NANC
relaxations, the effects of L-NAME (10-4 M), a competitive inhibitor of NO-synthase
(Rees, Palmer, Schultz, Hodson & Moncada, 1990), was tested. These experiments
were carried out in the presence of atropine (10-6 M) and guanethidine (10-6 M) in
order to reduce adrenergic and cholinergic responses. An example of one such
experiment is shown in Fig. 2. Before exposure to L-NAME, relaxations occurred in
response to stimulus frequencies of 0-2-4 Hz and prominent rebound contractions
occurred at the ends of the stimulus periods (Fig. 2, top trace). L-NAME (10-4 M) had
no effect on baseline tone, but abolished the relaxations evoked by 0-2 Hz stimulation
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Fig. 1. Responses of the bladder neck muscle to 1 min periods of field stimulation at
freqoencies 0fO2-8 Hz in the presence ofKrebs solution (upper trace), and in tetrodotoxin
(ito6 M; lowee trace).
Control
2 mN
mrnin
L-NAME
L-NAME + L-arginine
0.2 Hz 0.5 Hz 1 Hz 2 Hz 4 Hz
Fig. 2. R.elaxations and 'rebound contractions' in response to 1 min periods of field
stimulation at 02-4 Hz in Krebs solution containing atropine (10-6 M) and guanethidine
(10-6 M) (top trace); after addition ofL-NAME (10-4 M) (middle trace); and after addition
of L-NAME (10-4 M) and L-arginine (10-3 M) (bottom trace).
and greatly reduced the relaxations and rebound contractions at all other frequencies
(Fig. 2, middle trace), thus suggesting that both responses depended on synthesis of
NO. In other types of smooth muscle the effects of NO-synthase inhibitors such as
L-NAMIg can be competitively reversed by L-arginine, but not by D-arginine (Gibson
et al. 1990; Dalziel et al. 1991; Desai et al. 1991). Figure 2 (bottom trace) shows that,
in the bladder neck muscle, L-arginine (10-3 M) partly reversed the effects of L-
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NAME, restoring both the relaxations and the rebound contractions throughout the
range of stimulus frequencies. In contrast, D-arginine (10-3 M) was without effect (n
- 3; not shown). A summary of the effects of L-NAME (10-4 M) and L-arginine
(L0-3 M) in eleven experiments is presented in Fig. 3. The mean effect ofL-NAME was
0*8 0-2 Hz 0*5 Hz 1 Hz 2 Hz 4 Hz
z 08-
E E0-6 -*
'r 0.4-
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Fig. 3. Summary of the effects Of L-NAME (10-4 M) and L-NAME (10-4 M) + L-arginine(10-' M) on the responses to field stimulation (n = 11). Atropine (1o-6 M) and guanethidine(10-6 M) were present throughout. Upper panel indicates responses occurring during the
1 min periods of field stimulation, lower panel indicates rebound contractions occurring
after field stimulation. Columns represent mean responses before addition of L-NAME
(La), in presence ofL-NAME (U), and in presence ofL-NAME + L-arginine (0). Error bars
represent 1 S.E.M. * significant depression in presence of L-NAME (P < 0 05), t significant
recovery in L-NAME and L-arginine (P< 0-05).
to significantly reduce the relaxations evoked by stimulus frequencies 02-1 Hz,
while at 2-4 Hz the relaxations were converted to contractions (Fig. 3, upper panel).
These effects were significantly reversed by L-arginine, thus providing further
support for the hypothesis that the relaxations depended on synthesis of NO. The
rebound contraction was also significantly reduced by L-NAME at all stimulus
frequencies, and there was a clear trend for this to be reversed by L-arginine,
although the effect was only statistically significant at 4 Hz stimulation (Fig. 3, lower
panel).
Effect of S-nitroso-L-cysteine
If the NANO relaxations are mediated by NO, it ought to be possible to mimic the
effects of nerve stimulation by applying exogenous NO to the preparation. Therefore
the effect ofS-nitroso-L-cysteine, a NO-releasing compound and putative endogenous
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Fig. 4 A, response of a bladder neck muscle strip to exposure to S-nitroso-L-cysteine (Cys-
NO; 1P6 x 10-1 M) for 1 min. Strip was precontracted with noradrenaline (10-6 M). B, strip
was precontracted with noradrenaline (Nor; 10-5 M) and then exposed to cumulative
concentrations of S-nitroso-L-cysteine (10-8-10-3 M); doses expressed as -log [S-nitroso-
L-cysteine]. The bath was continuously aerated with 02 (95 %) and CO2 (5 %) and was not
perfused during the additions of S-nitroso-L-cysteine. C, cumulative dose-response
relationship for S-nitroso-L-cysteine (n = 7; * indicate means; bars indicate+s.E.M.).
Strips were precontracted with noradrenaline (10-5 M). Relaxations are normalized to the
maximum relaxation, (obtained at S-nitroso-L-cysteine, 10-3 M) and plotted against -log
[S-nitroso-L-cysteine].
carrier of NO (Ignarro, 1990; Myers et al. 1990) was examined to see if it mimicked
the effects of nerve stimulation. S-Nitroso-L-cysteine caused rapid relaxation of the
bladder neck muscle and, when brief additions and rapid washouts were performed,
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there were also rebound contractions (Fig. 4A). Thus, S-nitroso-L-cysteine could
mimic both of the components ofNANC nerve stimulation. The ability of S-nitroso-
L-cysteine to relax the tissue was quantified by examining the effects of cumulative
additions to tissue precontracted with noradrenaline (10- M). Noradrenaline induced
A Control 2-Methylthio ATP
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1 Hz 2 Hz
a,/-Methylene ATP
V-
1 Hz
C
0-
0.1 -
0o2 -
z
E 03-
Xu 05 -
c:
0 6 -
0*7 -
0 8 -
L2H
2 Hz
L-I
--I
1 Hz
1 Hz
AI
2 Hz
1 Hz
Control
Hsa,f-Methylene ATP
2-Methylthio ATP
Fig. 5. A, effect of 2-methylthio ATP (10-1 M) on response to 1 Hz and 2 Hz field
stimulation. B, effect of a,fi-methylene ATP (10-1 M) on response to 1 Hz and 2 Hz field
stimulation. Control responses were obtained in Krebs solution in each case. C, summary
of the effect of 2-methylthio ATP (10-1 M) and a,,-methylene ATP (10- M) on relaxations
in response to 1 Hz stimulation. Each column refers to the mean response of six
preparations. Each preparation was used once only, first to test the control response in
Krebs solution (LI) and then during perfusion of either 2-methylthio ATP (1E1) or a,,-
methylene ATP (v).
1 Hz
B Control
----A--- -V ---
) by guest on March 8, 2012jp.physoc.orgDownloaded from J Physiol (
140 K. D. THORNBUR Y, M. A. HOLLYWOOD AND N. G. MaHALE
contractures averaging 2-72 + 0-36 mN and these were dose-dependently reduced by
S-nitroso-L-cysteine (10-7-10-3 M; e.g. Fig. 4B). Threshold concentrations necessary
to cause relaxation varied from 10-8 to 10-7 M between tissues, and maximal
relaxations occurred at 10-1-10-3 M, at which concentrations tone was reduced to
below the pre-noradrenaline resting level. These effects were reversible on wash (not
shown). A summary of the mean responses to cumulative additions of S-nitroso-L-
cysteine in seven preparations is shown in Fig. 4C.
Effects of 2-methylthio ATP and a,c-methylene ATP
High concentrations of ATP have also been shown to cause relaxation in the
bladder internal sphincter (Hills et at. 1984; Klarskov, 1987). The possibility that
ATP participated in the relaxations evoked by nerve stimulation was tested by
exposing the tissues to ATP analogues in order to desensitize ATP receptors.
Preparations were first stimulated under control conditions (no drugs present), and
then stimulation was repeated after at least 30 min exposure to either the P2Y
receptor agonist, 2-methylthio ATP (10-s M), or the P2x receptor agonist, a,,J-
methylene ATP (10-5 M). Typical examples of the effects of these compounds on
nerve stimulation are shown in Fig. 5. Neither compound affected the basal tone or
the relaxations evoked by nerve stimulation, suggesting that P2 receptors did not
participate in the nerve-evoked responses. Summary data of the effects of 2-
methylthio ATP (n = 6) and c,fl-methylene ATP (n = 6) on relaxations induced by
1 Hz stimulation are presented in Fig. 5C. Neither drug produced any significant
change in the relaxation (Fig. 5C), or the rebound contraction (not shown).
DISCUSSION
Despite early reports which postulated the existence of antagonistic inhibitory and
excitatory nerves to the internal urethral sphincter (Barrington, 1914, 1933), for
most of the last fifty years the accepted view has been that the opening of this muscle
was an entirely passive process (Kuru, 1965; Denny-Brown & Robertson, 1933 a). It
was argued that the sphincter could not be opened independently of contraction of
the detrusor muscle (Kuru, 1965; Denny-Brown & Robertson, 1933 b), and
hypothesized that the fibres of the sphincter continued into the base of the detrusor
in such a manner that when the latter contracted it pulled open the sphincter (Kuru,
1965; Denny-Brown & Robertson, 1933 a). This view, however, was challenged when
it was demonstrated that stimulation of the sacral parasympathetic nerves in the
human female could produce a fall in intra-urethral pressure without changing
vesicular pressure (Torrens, 1978). It was proposed that active relaxation of the
sphincter occurred in response to stimulation of parasympathetic inhibitory nerves.
Subsequently, neurogenic relaxation of the bladder neck muscle and proximal
urethra has been shown to occur in vitro in humans (Andersson et al. 1983), rabbits
(Mattiasson et al. 1990) and pigs (Klarskov et al. 1983; Hills et al. 1984; Klarskov,
1987). Although several attempts have been made to identify the NANC
neurotransmitter(s) mediating these responses, no satisfactory candidate has been
established. Vasoactive intestinal polypeptide (VIP) was found to cause relaxation
which could be antagonized by chymotrypsin (Hills et at. 1984) or VIP antiserum
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(Klarskov, 1987); however, neither treatment altered the relaxations evoked by
nerve stimulation. Similarly, high doses of ATP (10-5-10-3 M) caused relaxation, but
desensitization to ATP or ct,,-methylene ATP (Hills et al. 1984; Klarskov, 1987)
failed to alter the response to nerve stimulation. Adenosine and 5-HT produced
relaxations which were inhibited by 8-phenyltheophylline and methysergide,
respectively, but again these antagonists failed to modify the nerve-mediated
relaxations (Hills et al. 1984).
The recent identification of several highly specific inhibitors of NO-synthase
(Palmer et al. 1988; Rees et al. 1990) has lead to the discovery that NO is involved
in mediating NANC inhibitory responses in a number of other visceral smooth muscle
preparations (Gillespie et al. 1989; Bult, et al. 1990; Gibson et al. 1990; Ignarro et al.
1990; Boeckxstaens et al. 1991; Dalziel et al. 1991; Desai et al. 1991; Thornbury et al.
1991). Our experiments now strongly suggest that this system is also responsible for
a large component of the NANC relaxations of the bladder neck muscle. This view
is supported by the following pieces of evidence: (1) the relaxations were reduced or
abolished by L-NAME, a competitive inhibitor of Ca2+-calmodulin-dependent NO-
synthase; (2) the effect of L-NAME was partially reversed by L-arginine, the
endogenous substrate for NO synthase, but was not affected by D-arginine; (3)
exogenously applied S-nitroso-L-cysteine, a substance which spontaneously releases
NO (Ignarro, 1990; Kowaluk & Fung, 1990; Myers et al. 1990; Bates et al. 1991)
mimicked the relaxations caused by nerve stimulation. In this respect, the three
criteria which are most commonly applied to establish NO as an important link in the
process of inhibitory neurotransmission in other tissues (Gillespie et al. 1989; Gibson
et al. 1990; Ignarro et al 1990; Boeckxstaens et al. 1991; Dalziel et al. 1991; Desai
et al. 1991) have now been satisfied in the bladder. In the gastrointestinal tract two
other points have strengthened this argument: (1) bioassay experiments have
directly demonstrated TTX-sensitive release of NO-like substance upon field
stimulation (Bult et al. 1990), and (2) Ca2+-calmodulin-dependent NO-synthase has
been shown to be present in the nerves of the myenteric plexus (Bredt et al. 1990).
These experiments provide circumstantial evidence that NO may be released from
nerves and have led to the proposal that NO is the actual inhibitory neurotransmitter
(Bult et al. 1990). However, since NO-synthase is also present in endothelial cells (and
possibly other cells), release of NO from a non-neural cell in response to release of
another neurotransmitter cannot be excluded. In the present study we re-examined
the role to ATP as a potential neurotransmitter which might perform this function.
We felt that this was necessary since this substance is now known to release NO from
vascular endothelial cells via an action on P2Y receptors (Mathie, Ralevic, Alexander
& Burnstock, 1991; Ralevic, Mathie, Alexander & Burnstock, 1991), a fact not
known to previous workers who investigated the innervation of the bladder internal
sphincter (Hills et al. 1984; Klarskov, 1987). Our results showed that the P2, receptor
agonist, 2-methylthio ATP, failed to cause relaxation or interfere with the inhibitory
responses to nerve stimulation, and confirmed the lack of effect of the P2X receptor
agonist, a,,I-methylene ATP, described previously (Hills et al. 1984). These results
suggest that it is unlikely that the final neurotransmitter is ATP. They do not,
however, exclude the possibility that ATP may be a neurotransmnitter in the
inhibitory pathway, which then causes NO release from the final neurone in the path.
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Such a mechanism has been proposed to explain ATP-mediated relaxations in the
dog ileocolonic junction, which are TTX- and L-NAME-sensitive (Boeckxstaens et al.
1991). Some of the other putative neurotransmitters referred to above could operate
in this way since blocking their action with antagonists or by desensitization of
receptors would not be expected to block the effects of field stimulation on the final
nerve in the pathway. The question of which putative neurotransmitters cause TTX-
sensitive release of NO in the bladder neck muscle warrants further investigation,
but this was beyond the scope of the present study.
Even if it was proven that NO is released from nerves it might never be regarded
as a neurotransmitter in the classical sense. Firstly, it is thought to exert most of its
effects by acting intracellularly rather than via surface receptors (for review see
Ignarro, 1990). Secondly, NO is an extremely lipophilic, labile substance which could
not be stored easily in nerve vesicles. This necessitates proposing non-classical
models to explain release in response to nerve stimulation. One such model proposes
that NO is synthesized de novo as a result of an influx of Ca2l into the nerve terminal,
which then activates the Ca2+-calmodulin-dependent synthase enzyme (Gar-
thwaite, 1991). Alternatively, NO might be stored in vesicles if combined with
another molecule to produce a more stable complex. S-Nitroso-L-cysteine has been
proposed as the naturally occurring carrier for NO in vascular endothelial cells
(Ignarro, 1990; Myers et al. 1990). Direct chemiluminescent measurements have
demonstrated that NO is spontaneously liberated into the headspace of solutions of
S-nitroso-L-cysteine (and similar S-nitrosothiols) in oxygenated Krebs buffer at
37 °C (Kowaluk & Fung, 1990). S-Nitroso-L-cysteine is relatively stable under acidic
conditions but at pH 7'4 spontaneously liberates NO with a half-life of 15-30 s
(Myers et al. 1990; Bates et al. 1991). It has been suggested that S-nitroso-L-cysteine
is stored intracellularly in acidified vesicles and spontaneously degrades to release NO
when the contents of the vesicle are expelled into the extracellular space (Ignarro,
1990). Electrophysiological studies in the canine colon have demonstrated that S-
nitroso-L-cysteine is indistinguishable from NO in its ability to cause smooth muscle
hyperpolarization (Thornbury et al. 1991). This suggests that this substance degrades
to produce NO quickly enough (at least under experimental conditions) to account
for changes attributed to endogenous release of NO. In the present study S-nitroso-
L-cysteine produced relaxations and rebound contractions similar to the effects of
nerve stimulation, making it a possible candidate for the substance released from the
inhibitory nerves of the bladder.
The results of the present study demonstrate that NANC relaxation and rebound
contraction in the smooth muscle sphincter of the bladder depend on the synthesis
and release of NO, or a closely related compound. While it seems attractive to
speculate that a response characterized by rapid relaxation followed by abrupt
contraction would be ideally suited to participate in the normal voiding cycle of
micturition, the previous lack of a specific antagonist for these nerves has made their
physiological importance difficult to evaluate (Klarskov et al. 1983; Mattiasson et al.
1990). The demonstration that relaxation of the internal sphincter is antagonized by
the NO-synthase inhibitor, L-NAME, provides an opportunity to assess the role of
inhibitory NANC nerves in vivo, and may improve our understanding of clinical
conditions such as stress incontinence, urge incontinence and urinary retention.
) by guest on March 8, 2012jp.physoc.orgDownloaded from J Physiol (
INHIBITORY NERVES OF THE BLADDER 143
The authors wish to thank Bangor Meats for supplying sheep bladders.
REFERENCES
ANDERSSON, K.-E., MATTIASSON, A. & SJOGREN, C. (1983). Electrically induced relaxation of the
noradrenaline contracted urethra from rabbit and man. Journal of Urology 129, 210-214.
BARRINGTON, F. J. F. (1914). The nervous mechanism of micturition. Quarterly Journal of
Experimental Physiology 8, 33-71.
BARRINGTON, F. J. F. (1933). The component reflexes of micturition in the cat. Brain 54, 177-188.
BATES, J. N., ALDAPE, G. & BAKER, M. T. (1991). Nitric oxide production by S-nitroso-L-cysteine.
FASEB Journal 5, A1220.
BOECKXSTAENS, G. E., PELCKMANS, P. A., BULT, H., DE MAN, J. G., HERMAN, A. G. & VAN
MAERCKE, M. (1991). Evidence for nitric oxide as mediator of non-adrenergic, non-cholinergic
relaxations induced by ATP and GABA in the canine gut. British Journal of Pharmacology 102,
434-438.
BREDT, D. S., HWANG, P. H. & SNYDER, S. H. (1990). Localization of nitric oxide synthase
indicating a neural role for nitric oxide. Nature 347, 768-770.
BULT, H., BOECKXSTAENS, G. E., PELCKMANS, P. A., JORDAENS, F. H., VAN MAERCKE, Y. M. &
HERMAN, A. G. (1990). Nitric oxide as an inhibitory non-adrenergic, non-cholinergic
neurotransmitter. Nature 345, 346-347.
DALZIEL, H. H., THORNBURY, K. D., WARD, S. M. & SANDERS, K. M. (1991). Involvement of the
nitric oxide synthetic pathway in inhibitory junction potentials in canine proximal colon.
American Journal of Physiology 260, G789-792.
DENNY-BROWN, D. & ROBERTSON, E. G. (1933a). On the physiology of micturition. Brain 56,
149-190.
DENNY-BROWN, D. & ROBERTSON, E. G. (1933b). The state of the bladder and its sphincters in
complete transverse lesions of the spinal cord and cauda equina. Brain 56, 397-463.
DESAI, K. M., SESSA, W. C. & VANE, J. R. (1991). Involvement of nitric oxide in the reflex
relaxation of the stomach to accommodate food or fluid. Nature 351, 477-479.
FIELD, L., DILTS, R. V., RAVICHANDRAN, R., LENHERT, P. G. & CARNAHAN, G. E. (1978). An
unusually stable thionitrite from N-acetyl-D-L-penicillamine; X-ray crystal and molecular
structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite. Journal of the Chemical
Society: Chemical Communications 249-250.
GARTHWAITE, J. (1991). Glutamate, nitric oxide and cell-cell signalling in the nervous system.
Trends in Neurosciences 14, 6067.
GIBSON, A., MIRZAZADEH, S., HOBBS, A. J. & MOORE, P. K. (1990). L-NG-Monomethyl arginine and
L-N0-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse ano-
coccygeus muscle. British Journal of Pharmacology 99, 602-606.
GILLESPIE, J. S., XIARONG, L. & MARTIN, W. (1989). The effects of L-arginine and NVG-monomethyl-
L-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation. British
Journal of Pharmacology 98, 1080-1082.
HILLS, J., MELDRUM, L. A., KLARSKOV, P. & BURNSTOCK, G. (1984). A novel non-adrenergic, non-
cholinergic nerve mediated relaxation of the pig bladder neck: an examination of possible
neurotransmitter candidates. European Journal of Pharmacology 99, 287-293.
IGNARRO, L. J. (1990). Nitric oxide: a novel signal transduction mechanism for transcellular
communication. Hypertension 16, 447-483.
IGNARRO, L. J., BUSH, P. A., BUGA, G. M., WOOD, K. S., FUKUTO, J. M. & RAJFER, J. (1990). Nitric
oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus
cavernosum smooth muscle. Biochemical and Biophysical Research Communications 170, 843-850.
KLARSKOV, P. (1987). Non-adrenergic, non-cholinergic inhibitory nerve responses of bladder outlet
in vitro. British Journal of Urology 60, 337-342.
KLARSKOV, P., GERSTENBERG, T. C., RAMIREZ, D. & HALD, T. J. (1983). Non-adrenergic, non-
cholinergic nerve mediated relaxation in trigone, bladder neck and urethral smooth muscle in
vitro. Journal of Urology 129, 848-850.
KOWALUK, E. A. & FUNG, H-L. (1990). Spontaneous liberation of nitric oxide cannot account for
in vitro relaxation by S-nitrosothiols. Journal of Pharmacology and Experimental Therapeutics
255, 1256-1264.
) by guest on March 8, 2012jp.physoc.orgDownloaded from J Physiol (
144 K. D. THORNBUR Y, M. A.HOLLYWOOD AND N. 0. MeHALE
KURU, M. (1965). Nervous control of micturition. Physiological Reviews 54, 425-494.
MATHIE, R. T., RALEVIC, V., ALEXANDER, B. & BURNSTOCK, G. (1991). Nitric oxide is the mediator
of ATP-induced dilatation of the rabbit hepatic arterial vascular bed. British Journal of
Pharmacology 103, 1602-1606.
MATTIASSQN, A., ANDERSSON, K., ANDERSSON, P., LARSSON, B., SJOGREN, C. & UVELIUS, B. (1990).
Nerve-mediated function in the circular and longitudinal muscle layers of the proximal female
rabbit urethra. Journal of Urology 143, 155-160.
MYERS, P. R., MINOR, R. L., GUERRA, R., BATES, J. N. & HARRISON, D. G. (1990). Vasorelaxant
properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine
than nitric oxide. Nature 345, 161-163.
PALMER, At. M. J., ASHTON, D. S. & MONCADA, S. (1988). Vascular endothelial cells synthesize nitric
oxide from L-arginine. Nature 333, 664-666.
RALEVIC, V., MATHIE, R. T., ALEXANDER, B. & BURNSTOCK, G. (1991). Characterization of P2X-
and P2Y-purinoceptors in the rabbit hepatic arterial vasculature. British Journal ofPharmacology
103, 1108-1113.
REES, D. D., PALMER, R. M. J., SCHULTZ, R., HODSON, H. F. & MONCADA, S. (1990). Charac-
terization of three inhibitors of endothelial nitric oxide synthase in vivo and in vitro. British
Journal of Pharmacology 101, 746-752.
THORNBURY, K. D., WARD, S. M., DALZIEL, H. H., CARL, A., WESTFALL, D. P. & SANDERS, K. M.
(1991). Nitric oxide and nitrosocysteine mimic non-adrenergic, non-cholinergic hyper-
polarization in canine proximal colon. American Journal of Physiology 261, G553-557.
TORRENS, M. J. (1978). Urethral sphincteric responses to stimulation of the sacral nerves in the
human female. Urologia Internationalis 33, 22-26.
) by guest on March 8, 2012jp.physoc.orgDownloaded from J Physiol (
